Using Bax/Bak knockout AML cells as well as caspase inhibitors and blocking antibodies, we demonstrate that, mechanistically, the extrinsic pathway is not a significant contributor to this combinatorial efficacy. This evidence concerns the gene BAK1 and acute myeloid leukemia.